These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5220247)

  • 1. Comparison of ethambutol-INH versus INH-PAS in original treatment of pulmonary tuberculosis.
    Bobrowitz ID
    Ann N Y Acad Sci; 1966 Apr; 135(2):921-39. PubMed ID: 5220247
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethambutol: a substitute for para-aminosalicylic acid in regimens for pulmonary tuberculosis.
    Ferebee SH; Doster BE; Murray FJ
    Ann N Y Acad Sci; 1966 Apr; 135(2):910-20. PubMed ID: 5220246
    [No Abstract]   [Full Text] [Related]  

  • 3. Retreatment of pulmonary tuberculosis with ethambutol.
    Gómez-Pimienta JL; Shibayama Hernández H; Pérez Fernández LF; Pérez Herrera R; García Oranday O
    Ann N Y Acad Sci; 1966 Apr; 135(2):882-9. PubMed ID: 4957086
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy of pulmonary tuberculosis].
    Ludes H
    Dtsch Med Wochenschr; 1972 Feb; 97(8):289-91. PubMed ID: 5058425
    [No Abstract]   [Full Text] [Related]  

  • 6. The predictability of hypersensitivity to anti-tuberculous drugs.
    Thompson JE
    Aust N Z J Med; 1973 Jun; 3(3):239-44. PubMed ID: 4517219
    [No Abstract]   [Full Text] [Related]  

  • 7. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
    Knop P; Kindler U; Merholz T
    Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs in the treatment of tuberculosis--1969.
    Beacham EG
    Johns Hopkins Med J; 1969 Nov; 125(5):286-90. PubMed ID: 5366128
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent drugs in the treatment of primary tuberculosis].
    Gerbeaux J; Hanoteau J
    Rev Tuberc Pneumol (Paris); 1971; 35(3):315-25. PubMed ID: 5315164
    [No Abstract]   [Full Text] [Related]  

  • 11. Ambulatory management of tuberculosis.
    Hampton JR; Bates JH
    Am Fam Physician; 1974 Nov; 10(5):204-10. PubMed ID: 4214055
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. I. Clinical comparison of SM, INH and EB regimen with SM, INH and PAS regimen].
    Makiyama H
    Kekkaku; 1969 Jun; 44(6):181-7. PubMed ID: 5805784
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined antitubercular treatment of pulmonary tuberculosis in adults].
    Böszörményi M
    Orv Hetil; 1970 Mar; 111(11):603-8. PubMed ID: 4911914
    [No Abstract]   [Full Text] [Related]  

  • 14. A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 2.
    Oka S; Kayaba K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):106-9. PubMed ID: 5525311
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of acceptable and adequate outpatient treatment on the length of hospitalization and on readmission for relapse or reactivation of pulmonary tuberculosis.
    Curry FJ
    Chest; 1973 Apr; 63(4):536-46. PubMed ID: 4633013
    [No Abstract]   [Full Text] [Related]  

  • 16. [New drugs in antitubercular therapy].
    Favez G
    Helv Med Acta Suppl; 1969; 49():66-80. PubMed ID: 4912509
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of tuberculosis.
    Lester W
    Clin Notes Respir Dis; 1970; 9(2):3-13. PubMed ID: 4319281
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)].
    Bignall JR
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):103-6. PubMed ID: 4588016
    [No Abstract]   [Full Text] [Related]  

  • 20. [The course of pulmonary tuberculosis in the initial phase of various intensive therapy combinations].
    Kindler U; Derichs R; Merholz S
    Med Welt; 1976 Feb; 27(8):387-8. PubMed ID: 1256307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.